Dr Yiping Chen
|Tel||+44 (0)1865 743836|
MRC study coordinator and senior investigator scientist
Yiping Chen is a senior research fellow at the CTSU, University of Oxford. She qualified in clinical medicine in 1985 at Shanghai Medical University (now Fudan University) and then worked as junior neurologist in University affiliated teaching hospital, Hua-shan hospital in Shanghai. In 1988 she was awarded Sino-British Friendship Scholarship to study in the UK and gained her PhD at University of Oxford in 1993. She joined CTSU in 1998 and has worked as study coordinator and senior research fellow in several CTSU-led large clinical trials such as COMMIT/CCS2, SHARP, HPS2-THRIVE, REVEAL. She is currently leading a multi-disciplinary team in the China Kadoorie Biobank (CKB) of 0.5 million people, responsible for developing strategies and procedures related to validation of electronically reported clinical events and for conducting disease validation and adjudication in collaboration with clinical specialists in China for CKB. She also plays a leading role in running Oxford-China Fellowship programmes which provides residence training in epidemiology, medical statistics and clinical trials methodology for the clinical doctors, public health workers from China. Her main research interests are in the fields of clinical epidemiology of cardiovascular diseases, major depression, and sleeping disorders.
Associations of domain-specific physical activities with insomnia symptoms among 0.5 million Chinese adults.
Zheng B. et al, (2017), J Sleep Res
Association between diabetes and cause-specific mortality in rural and urban China
Bragg F. et al, (2017), JAMA
Tea consumption and risk of ischaemic heart disease.
Li X. et al, (2017), Heart
Season of birth and the risk of type 2 diabetes in adulthood: a prospective cohort study of 0.5 million Chinese adults.
Si J. et al, (2017), Diabetologia
Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies.
Pang Y. et al, (2017), Int J Cancer